Ovesco Named Financial Times Long-Term Growth Champion

Tuebingen, 12.11.2024. Ovesco Endoscopy AG has been recognized as one of Europe’s Long-Term Growth Champions by the Financial Times in collaboration with Statista. The list comprises companies that have demonstrated consistent sales growth for at least ten years. Ovesco is one of the top 10 companies in the Healthcare and Life Sciences sector. Ovesco is a pioneer in the medical technology industry in the field of flexible endoscopy and has continued to expand its presence around the world over the last ten years.

The Long-Term Growth Champion Ranking has been presented for the first time this year and recognizes the top 300 European companies that have shown consistent sales growth over the last ten years. With a compound annual growth rate (CAGR) of 23.6% since 2013, Ovesco is one of the top 10 Long-Term Growth Champions in the Healthcare & Life Sciences category.

With innovative products for flexible endoscopy, Ovesco has established a firm place in the medical technology industry and offers a wide range of innovative products, including OTSC®neo for hemostasis and the safe closure of perforations or fistulas in the gastrointestinal tract, FTRD® for full-thickness resection, for example for early carcinomas, and ScopeCaps, caps for endoscopes that make the work of medical professionals easier in various applications, for example in the removal of foreign bodies from the oesophagus.

“We are very proud to have been named Long-Term Growth Champion” explains Professor Dr. Marc Schurr, CEO of Ovesco. “This award is a testament to the strength and commitment of our entire team. We focus on innovative products and continuous development in order to expand the possibilities of flexible endoscopy and improve patient care. We look forward to continuing to excel with our products in the future and to growing further worldwide.”

About Ovesco Endoscopy AG

Product innovation is one of Ovesco’s core competencies. prognos and the F.A.Z Institute list the medical technology company as one of Germany’s innovation leaders. This confirms the research strength of the Tübingen-based company, which has repeatedly been awarded national innovation and industry prizes.
Cooperation with leading doctors in science and training is of outstanding importance to Ovesco. As a research-based medical technology company, Ovesco is in constant collaboration with clinicians on new product ideas, clinical studies and the introduction of new procedures in medical training. The Ovesco team is fully committed to developing products of outstanding quality and exceptional medical benefit and bringing them to the clinic. Ovesco has sites in Germany, France, India and the USA.

Contact

Alicia Pulfermuller
Director Marketing
Ovesco Endoscopy AG
Friedrich-Miescher-Str. 9
72076 Tübingen
Tel. +49 7071 96528 182
alicia.pulfermuller@ovesco.com
www.ovesco.com